The study set out to assess the feasibility of using ParsortixTM circulating tumour cell (CTC) extraction and CytoFoam Disc cell‐block immunohistochemistry to diagnose metastatic carcinoma from blood samples in a… Click to show full abstract
The study set out to assess the feasibility of using ParsortixTM circulating tumour cell (CTC) extraction and CytoFoam Disc cell‐block immunohistochemistry to diagnose metastatic carcinoma from blood samples in a National Health Service district general hospital.
               
Click one of the above tabs to view related content.